A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Alzheimer's Disease, Mild Cognitive Impairment

In brief

Based on prior published pilot studies, the investigators have initiated a larger, multi-site placebo-controlled clinical trial with Alzheimer's disease (AD) patients and individuals diagnosed with Mild Cognitive Impairment (MCI), with the hopes of (1) confirming (or denying) the above promising clinical findings, and (2) determining whether or not our formulation can delay MCI "conversion" to AD.

Key facts

Study ID

NCT01320527

Run by

University of Massachusetts, Worcester

People needed

135

Starts

2008-08-01

Expected to finish

2012-04-01

Last updated by the study team

2016-03-03

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Alzheimer's disease or Mild Cognitive Impairment
• must be able to swallow pills

You may not qualify if…

• known or suspected bipolar disorder

Where it is running

• Naples Medical Center — Naples, Florida, United States
• University of Maryland — Baltimore, Maryland, United States
• Primary Care Cardiology Research — Ayer, Massachusetts, United States
• Rivercourt Residences — Groton, Massachusetts, United States
• Mary Immaculate Residential — Lawrence, Massachusetts, United States
• D'Youville Senior Care — Lowell, Massachusetts, United States
• Neurocognitive Institute — Mount Arlington, New Jersey, United States
• Advanced Memory Dynamics — Layton, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.